Empowering researchers worldwide.

Proteios is on a mission to empower preclinical researchers by providing access to biologicals in order to better understand the molecular basis of disease and discover new advanced therapeutics.

Our Story

We are a team of scientists and bioengineers based in Seattle, WA.

We value humility, empathy, sustainability, and resilience - in life and at work.

Proteios was founded in 2015 to share our novel protein purification technology that was developed at the University of Washington with the research community. The technology is now being expanded to provide for the label-free isolation of any biological, including immune cells and antibodies. 

We believe cell therapies are the future of medicine and that we have a responsibility to make those therapies available to everyone.

Leadership

Bob Snyder, Ph.D./MBA  

Bob is Cofounder and CEO at Proteios and has over 30 years’ experience in life science research and commercialization. He has a Ph.D. in Biochemistry from the University of California, Santa Barbara and an MBA from the University of Chicago Graduate School of Business. Bob previously held executive positions with Abbott Laboratories, Merck & Co., FEI Company, and Elsevier Science.

François Baneyx, Ph.D. 

François is Cofounder and Scientific Advisor at Proteios and is currently Charles W.H. Matthaei Professor of Chemical Engineering, Director of CoMotion, and Vice Provost for Innovation at the University of Washington. He has a Ph.D. in Chemical Engineering from the University of Texas and is inventor of Proteios’ protein purification technology. 

Proteios Team

  • Alessio Ligabue, Ph.D.

    Principal Scientist

    LinkedIn

  • Shanqiao Wei, Ph.D.

    Senior Scientist

    LinkedIn

  • Anjala Bulathge, Ph.D.

    Research Scientist

    LinkedIn

  • Katie B Williams

    Operations Manager

    LinkedIn

  • Ian Mount

    Research Associate II

    LinkedIn

  • Cherry Leung, M.S.

    Bioengineer

    LinkedIn

  • Spencer Uyematsu

    Bioinformatics Scientist I

    LinkedIn

Our team of scientists, researchers, and bioengineering experts share a common mission to drive breakthroughs that improve the lives of patients.

Scientific Advisory Board

Andy Walker, Ph.D.

Cofounder, President & Chief Operating Officer, GentiBio

Marie-Andrée Forget, Ph.D.

 Principal Scientist, Cell Therapy Manufacturing Center

Stefan Radtke, Ph.D.

Senior Staff Scientist - Kiem Lab, Fred Hutchinson Cancer Research Center

Brian Till, M.D.

Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center

Monica Thakar, M.D.

Medical Director, Inpatient BMT, Seattle Children’s Hospital

Cliona Rooney, Ph.D.

Director of Translational Research Laboratories, Baylor College of Medicine

Rutilio Clark, Ph.D.

Scientific Director, Just - Evotec Biologics

Erik Vernet, Ph.D.

Senior Director of External Partnerships & Emerging Technologies, Novo Nordisk

We believe the intelligence and diversity of our collective immune systems will unlock discoveries that will change the way disease is treated. 

Our role is to open the doors for researchers to develop new cellular cures using nature’s most innately discerning disease fighters. 

Thank you to our partners in innovation.

  • University of Washington

  • UW CoMotion Incubator

  • Fisher Scientific

    RapidPro™ now available for purchase on Fisher.com!

  • National Institutes of Health (NIH)

  • National Cancer Institute (NCI)

  • National Science Foundation (NSF)

  • The Protein Society

  • Life Science Washington

  • Biocom California

Proteios is driven by the goal to lower the cost of healthcare and to provide advanced therapeutics to a larger patient population.